Clinical Trial Update: Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz. [Phase 4]

View source ↗

Summary

Phase 4 HIV trial evaluating immune reconstitution in treatment-naive patients with CD4 counts <100 cells/mL treated with lopinavir or efavirenz. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)
• Sustiva (efavirenz)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: HIV Infection | Phase 4 | Status: TERMINATED